Match tier Likely match
Presence Current · Arkansas
Last published 2025
Sources OpenAlex · ORCID
Refreshed 2026-10-08

James M. Oliphant

This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.

Role not yet determined Is this you? Add your title

NCTR

Also affiliated: Agricultural Research Service (2008); United States Food and Drug Administration (2024–2025); United States Department of Agriculture (2008); National Clonal Germplasm Repository (2008)

5 h-index 9 pubs 83 cited

Research Areas

Biomedical Subjects

  • Humans
  • Biomarkers
  • Animals
  • Liver
  • Hepatocytes
  • Chemical and Drug Induced Liver Injury
  • Lab-On-A-Chip Devices
  • Lipidomics
  • COVID-19
  • SARS-CoV-2
  • Severity of Illness Index
  • Metabolomics
  • Drug Development
  • Toxicity Tests
  • Myocytes, Cardiac

Links

Research Group

OverviewAI-generated summary

James M. Oliphant's research focuses on developing and validating methods for toxicity screening and drug development, particularly concerning drug-induced liver injury. He has investigated the use of lab-on-a-chip platforms for measuring biomarkers associated with liver damage and has explored the application of cardiac NAMs (New Approach Methodologies) for toxicity assessment. His work also extends to metabolomics and lipidomics, with recent efforts identifying disease severity biomarkers in COVID-19 patient plasma. Oliphant's scholarship metrics include an h-index of 5, with 9 total publications and 83 citations. He has collaborated with researchers such as Tucker A. Patterson, Laura K. Schnackenberg, Qiang Shi, and Katy S Papineau, all from the National Center for Toxicological Research, sharing one publication with each.

Metrics

  • h-index: 5
  • Publications: 9
  • Citations: 83

Selected Publications

  • Evaluation of BMI and fat distribution as potential risk factors for infection and wound healing complications in total hip arthroplasty (2026)
    Journal of Orthopaedic Reports DOI OpenAlex
  • Challenges and solutions in measuring commonly used biomarkers for drug-induced liver injury in a liver-on-a-chip platform (2025)
    Toxicology Letters 4 citations DOI OpenAlex
  • Validating and Using Cardiac NAMs for Toxicity Screening and Drug Development (2025)
    International Journal of Toxicology 3 citations DOI OpenAlex
  • Untargeted metabolomics and lipidomics in COVID-19 patient plasma reveals disease severity biomarkers (2024)
    Metabolomics 4 citations DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

45 Collaborators 30 Institutions 5 Countries

Top Collaborators

View profile →
View profile →

Similar Researchers

Based on overlapping research topics

Rohini Donakonda National Center for Toxicological Research
Metabolomics and Mass Spectrometry Techniques Pharmacological Effects and Toxicity Studies Disease Models, Animal
Good match 4 shared topics
Richard D. Beger National Center for Toxicological Research
Metabolomics and Mass Spectrometry Techniques Pharmacological Effects and Toxicity Studies Disease Models, Animal
Good match 4 shared topics
Lisa M. Pence National Center for Toxicological Research
Metabolomics and Mass Spectrometry Techniques Pharmacological Effects and Toxicity Studies Disease Models, Animal
Good match 4 shared topics
Vikrant Vijay National Center for Toxicological Research
Metabolomics and Mass Spectrometry Techniques Pharmacological Effects and Toxicity Studies Disease Models, Animal
Good match 4 shared topics
Anna Mazur University of Arkansas for Medical Sciences
Metabolomics and Mass Spectrometry Techniques Pharmacological Effects and Toxicity Studies Disease Models, Animal
Good match 3 shared topics
Shi Jesse Liu University of Arkansas for Medical Sciences
Pharmacological Effects and Toxicity Studies Disease Models, Animal Plant Physiology and Cultivation Studies
Good match 3 shared topics